Less Hype, More Ops: AI in the Real World

Your Eye Exam Isn't What You Think It Is

Most people think an eye exam is only about vision. It’s not. In the latest episode of I See What You Did There, we talk with optometrist Mark Schaeffer about what a comprehensive eye exam can actually reveal – from diabetes and high blood pressure to neurological conditions and stroke risk. Drawing from real patient stories, this episode highlights how a routine visit can uncover serious health issues long before symptoms appear, and why skipping your annual exam might mean missing something much bigger. Have an eye health-related idea for an upcoming episode? Drop us a line at blcommunications@bausch.com. Follow Bausch + Lomb on Facebook [https://www.facebook.com/BauschandLomb/], Instagram [https://www.instagram.com/bauschlomb/], LinkedIn [https://www.linkedin.com/company/bausch-&-lomb], X [https://x.com/bauschlomb] and YouTube [https://www.youtube.com/@BauschLomb1].

Less Hype, More Ops: AI in the Real World

AI only matters if it improves how work gets done. In the latest episode of I See What You Did There, we talk with Arena AI CEO and co-founder Pratap Ranade and Myko CEO and co-founder Trevor Lee about how AI is being embedded directly into operations at Bausch + Lomb and helping teams work smarter, not harder. From choosing the right problems to driving real adoption, this episode pulls back the curtain on what it really takes to turn AI from a promise into performance. Have an eye health-related idea for an upcoming episode? Drop us a line at blcommunications@bausch.com. Follow Bausch + Lomb on Facebook [https://www.facebook.com/BauschandLomb/], Instagram [https://www.instagram.com/bauschlomb/], LinkedIn [https://www.linkedin.com/company/bausch-&-lomb], X [https://x.com/bauschlomb] and YouTube [https://www.youtube.com/@BauschLomb1].

What, Precisely, Is Precision Medicine?

The latest episode of I See What You Did There explores one of the most talked-about — and often misunderstood — topics in modern medicine: precision medicine. Cheng Zhang, CEO and co-founder of Character Bio, and Mayssa Attar, Ph.D., head of Consumer and Pharmaceutical R&D at Bausch + Lomb, break down what precision medicine actually means, why it matters for patients and how applying genetics and data science to eye health could change how diseases are treated. It's a 20-minute chat on cutting-edge science that feels surprisingly human. Have an eye health-related idea for an upcoming episode? Drop us a line at blcommunications@bausch.com. Follow Bausch + Lomb on Facebook [https://www.facebook.com/BauschandLomb/], Instagram [https://www.instagram.com/bauschlomb/], LinkedIn [https://www.linkedin.com/company/bausch-&-lomb], X [https://x.com/bauschlomb] and YouTube [https://www.youtube.com/@BauschLomb1].

Changing the Game in Contact Lenses

The inaugural episode of I See What You Did There was recorded at the New York Stock Exchange and features Bausch + Lomb Vision Care President Yang Yang and Vision Care R&D Vice President Bryan Reed. Fresh from an appearance at Bausch + Lomb Investor Day, they explain why there hasn't been a contact lens material breakthrough in over 25 years and share details on an exciting pipeline product that could end that streak and create an entirely new category of lenses. Come for the science, stay for the Blockbuster Video shoutout. Curious about what else was shared at Investor Day? Watch a replay [https://www.webcaster5.com/Webcast/Page/2883/53072] of the webcast. Have an eye health-related idea for an upcoming episode? Drop us a line at blcommunications@bausch.com. Follow Bausch + Lomb on Facebook [https://www.facebook.com/BauschandLomb/], Instagram [https://www.instagram.com/bauschlomb/], LinkedIn [https://www.linkedin.com/company/bausch-&-lomb], X [https://x.com/bauschlomb] and YouTube [https://www.youtube.com/@BauschLomb1].